Global Radiopharmaceuticals in Nuclear Medicine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

REPORT SUMMARY
TABLE OF CONTENTS

Radiopharmaceuticals in Nuclear Medicine market report explains the definition, types, applications, major countries, and major players of the Radiopharmaceuticals in Nuclear Medicine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

The report contains qualitative and quantitative analysis of the entire industry.

The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

By Player:
- Lantheus Medical Imaging Inc
- IBA Group
- Institute of Isotopes Co Ltd
- Isotec Inc (Sigma-Aldrich)
- Covidien, Plc
- Cardinal Health Inc
- Siemens Healthcare (Subsidiary Of Siemens AG)
- Nordion Inc
- Cambridge Isotope Laboratories Inc
- Fujifilm Holdings Corporation
- GE Healthcare (Subsidiary Of General Electric Company)
- Board of Radiation And Isotope Technology (BRIT)
- Eczacibasi-Monrol
- Urenco Limited
- Institute of Atomic Energy Polatom Radioisotope Centre
- Rotem Industries Ltd Inc
- Taiyo Nippon Sanso Corporation
- Australian Nuclear Association And Technology Organization (ANSTO)
- Institute Of Radioelement (IRE)
- Ntp Radioisotopes (Pty) Ltd
- Bracco Imaging SPA
By Type:
- Diagnostic Radiopharmaceuticals
- Therapy Radiopharmaceuticals
- Enriched Stable Isotopes
By End-User:
- Diagnostic Application
- Therapeutic Application
- Research
- Pharmaceutical
- Other
By Region:

North America
- United States
- Canada
- Mexico
Europe
- Germany
- UK
- Spain
- France
- Italy
- Denmark
- Finland
- Norway
- Sweden
- Poland
- Russia
- Turkey
Asia-Pacific
- China
- Japan
- India
- South Korea
- Pakistan
- Bangladesh
- Indonesia
- Thailand
- Singapore
- Malaysia
- Philippines
- Vietnam
- Others
South America
- Brazil
- Colombia
- Chile
- Argentina
- Venezuela
- Peru
- Puerto Rico
- Ecuador
- Others
GCC
- Bahrain
- Kuwait
- Oman
- Qatar
- Saudi Arabia
- United Arab Emirates
Africa
- Nigeria
- South Africa
- Egypt
- Algeriat
- Others
Oceania
- Australia
- New Zealand
TABLE OF CONTENT
1. Global Radiopharmaceuticals in Nuclear Medicine Executive Summary
- 1.1 Introduction
- 1.2 Market Panorama, 2022
2 Coronavirus Impact
- 2.1 Radiopharmaceuticals in Nuclear Medicine Outlook to 2028- Original Forecasts
- 2.2 Radiopharmaceuticals in Nuclear Medicine Outlook to 2028- COVID-19 Affected Forecasts
- 2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
- 3.1 Potential Market Drivers and Opportunities
- 3.2 New Challenges and Strategies
- 3.3 Short Term and Long Term Radiopharmaceuticals in Nuclear Medicine Market Trends
4 Key Inferences
5 Market Overview
- 5.1 Current Market Scenario
- 5.2 Porter's Five Forces Analysis
6 Global Radiopharmaceuticals in Nuclear Medicine Market- Recent Developments
- 6.1 Radiopharmaceuticals in Nuclear Medicine Market News and Developments
- 6.2 Radiopharmaceuticals in Nuclear Medicine Market Deals Landscape
7 Radiopharmaceuticals in Nuclear Medicine Raw Materials and Cost Structure Analysis
- 7.1 Radiopharmaceuticals in Nuclear Medicine Key Raw Materials
- 7.2 Radiopharmaceuticals in Nuclear Medicine Price Trend of Key Raw Materials
- 7.3 Radiopharmaceuticals in Nuclear Medicine Key Suppliers of Raw Materials
- 7.4 Radiopharmaceuticals in Nuclear Medicine Market Concentration Rate of Raw Materials
- 7.5 Radiopharmaceuticals in Nuclear Medicine Cost Structure Analysis
8 Global Radiopharmaceuticals in Nuclear Medicine Import and Export Analysis (Top 10 Countries)
- 8.1 Global Radiopharmaceuticals in Nuclear Medicine Import by Region (Top 10 Countries) (2017-2028)
- 8.2 Global Radiopharmaceuticals in Nuclear Medicine Export by Region (Top 10 Countries) (2017-2028)
9 Global Radiopharmaceuticals in Nuclear Medicine Market Outlook by Types and Applications to 2022
- 9.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate by Type (2017-2022)
- 9.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate by Application (2017-2022)
10 Region and Country-wise Radiopharmaceuticals in Nuclear Medicine Market Analysis and Outlook till 2022
- 10.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption (2017-2022)
- 10.2 North America Consumption Analysis
- 10.3 Europe Consumption Analysis
- 10.4 APAC Consumption Analysis
- 10.5 South America Consumption Analysis
- 10.6 GCC Consumption Analysis
- 10.7 Africa Consumption Analysis
- 10.8 Oceania Consumption Analysis
11 Global Radiopharmaceuticals in Nuclear Medicine Competitive Analysis
- 11.1 Lantheus Medical Imaging Inc
- 11.2 IBA Group
- 11.3 Institute of Isotopes Co Ltd
- 11.4 Isotec Inc (Sigma-Aldrich)
- 11.5 Covidien, Plc
- 11.6 Cardinal Health Inc
- 11.7 Siemens Healthcare (Subsidiary Of Siemens AG)
- 11.8 Nordion Inc
- 11.9 Cambridge Isotope Laboratories Inc
- 11.10 Fujifilm Holdings Corporation
- 11.11 GE Healthcare (Subsidiary Of General Electric Company)
- 11.12 Board of Radiation And Isotope Technology (BRIT)
- 11.13 Eczacibasi-Monrol
- 11.14 Urenco Limited
- 11.15 Institute of Atomic Energy Polatom Radioisotope Centre
- 11.16 Rotem Industries Ltd Inc
- 11.17 Taiyo Nippon Sanso Corporation
- 11.18 Australian Nuclear Association And Technology Organization (ANSTO)
- 11.19 Institute Of Radioelement (IRE)
- 11.20 Ntp Radioisotopes (Pty) Ltd
- 11.21 Bracco Imaging SPA
12 Global Radiopharmaceuticals in Nuclear Medicine Market Outlook by Types and Applications to 2028
- 12.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate by Type (2022-2028)
- 12.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate by Application (2022-2028)
13 Country-wise Radiopharmaceuticals in Nuclear Medicine Market Analysis and Outlook to 2028
- 13.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption Forecast (2022-2028)
- 13.2 North America Consumption Analysis
- 13.3 Europe Consumption Analysis
- 13.4 APAC Consumption Analysis
- 13.5 South America Consumption Analysis
- 13.6 GCC Consumption Analysis
- 13.7 Africa Consumption Analysis
- 13.8 Oceania Consumption Analysis
14 Conclusions
The List of Tables and Figures
- Table Definition of Radiopharmaceuticals in Nuclear Medicine
- Figure of Radiopharmaceuticals in Nuclear Medicine Picture
- Table Global Radiopharmaceuticals in Nuclear Medicine Import by Region (Top 10 Countries) (2017-2028)
- Table Global Radiopharmaceuticals in Nuclear Medicine Export by Region (Top 10 Countries) (2017-2028)
- Figure Global Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
- Figure Global Therapy Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
- Figure Global Enriched Stable Isotopes Consumption and Growth Rate (2017-2022)
- Figure Global Diagnostic Application Consumption and Growth Rate (2017-2022)
- Figure Global Therapeutic Application Consumption and Growth Rate (2017-2022)
- Figure Global Research Consumption and Growth Rate (2017-2022)
- Figure Global Pharmaceutical Consumption and Growth Rate (2017-2022)
- Figure Global Other Consumption and Growth Rate (2017-2022)
- Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption by Country (2017-2022)
- Table North America Radiopharmaceuticals in Nuclear Medicine Consumption by Country (2017-2022)
- Figure United States Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Canada Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Mexico Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption by Country (2017-2022)
- Figure Germany Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure UK Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Spain Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Belgium Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure France Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Italy Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Denmark Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Finland Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Norway Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Sweden Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Poland Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Russia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Turkey Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Table APAC Radiopharmaceuticals in Nuclear Medicine Consumption by Country (2017-2022)
- Figure China Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Japan Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure India Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure South Korea Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Pakistan Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Bangladesh Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Indonesia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Thailand Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Singapore Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Malaysia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Philippines Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Vietnam Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Table South America Radiopharmaceuticals in Nuclear Medicine Consumption by Country (2017-2022)
- Figure Brazil Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Colombia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Chile Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Argentina Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Venezuela Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Peru Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Puerto Rico Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Ecuador Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Table GCC Radiopharmaceuticals in Nuclear Medicine Consumption by Country (2017-2022)
- Figure Bahrain Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Kuwait Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Oman Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Qatar Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure United Arab Emirates Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Table Africa Radiopharmaceuticals in Nuclear Medicine Consumption by Country (2017-2022)
- Figure Nigeria Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure South Africa Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Egypt Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure Algeria Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Table Oceania Radiopharmaceuticals in Nuclear Medicine Consumption by Country (2017-2022)
- Figure Australia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Figure New Zealand Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2017-2022)
- Table Lantheus Medical Imaging Inc Company Details
- Table Lantheus Medical Imaging Inc Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Lantheus Medical Imaging Inc Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Lantheus Medical Imaging Inc Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table IBA Group Company Details
- Table IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table IBA Group Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table IBA Group Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table Institute of Isotopes Co Ltd Company Details
- Table Institute of Isotopes Co Ltd Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Institute of Isotopes Co Ltd Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Institute of Isotopes Co Ltd Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table Isotec Inc (Sigma-Aldrich) Company Details
- Table Isotec Inc (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Isotec Inc (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Isotec Inc (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table Covidien, Plc Company Details
- Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table Cardinal Health Inc Company Details
- Table Cardinal Health Inc Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Cardinal Health Inc Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Cardinal Health Inc Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table Siemens Healthcare (Subsidiary Of Siemens AG) Company Details
- Table Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table Nordion Inc Company Details
- Table Nordion Inc Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Nordion Inc Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Nordion Inc Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table Cambridge Isotope Laboratories Inc Company Details
- Table Cambridge Isotope Laboratories Inc Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Cambridge Isotope Laboratories Inc Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Cambridge Isotope Laboratories Inc Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table Fujifilm Holdings Corporation Company Details
- Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table GE Healthcare (Subsidiary Of General Electric Company) Company Details
- Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table Board of Radiation And Isotope Technology (BRIT) Company Details
- Table Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table Eczacibasi-Monrol Company Details
- Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table Urenco Limited Company Details
- Table Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Urenco Limited Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table Institute of Atomic Energy Polatom Radioisotope Centre Company Details
- Table Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table Rotem Industries Ltd Inc Company Details
- Table Rotem Industries Ltd Inc Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Rotem Industries Ltd Inc Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Rotem Industries Ltd Inc Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table Taiyo Nippon Sanso Corporation Company Details
- Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table Australian Nuclear Association And Technology Organization (ANSTO) Company Details
- Table Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table Institute Of Radioelement (IRE) Company Details
- Table Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table Ntp Radioisotopes (Pty) Ltd Company Details
- Table Ntp Radioisotopes (Pty) Ltd Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Ntp Radioisotopes (Pty) Ltd Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Ntp Radioisotopes (Pty) Ltd Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Table Bracco Imaging SPA Company Details
- Table Bracco Imaging SPA Radiopharmaceuticals in Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Bracco Imaging SPA Radiopharmaceuticals in Nuclear Medicine Main Business and Markets Served
- Table Bracco Imaging SPA Radiopharmaceuticals in Nuclear Medicine Product Portfolio
- Figure Global Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Therapy Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Enriched Stable Isotopes Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Diagnostic Application Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Therapeutic Application Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Research Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Forecast by Country (2022-2028)
- Table North America Radiopharmaceuticals in Nuclear Medicine Consumption Forecast by Country (2022-2028)
- Figure United States Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Canada Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Mexico Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption Forecast by Country (2022-2028)
- Figure Germany Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure UK Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Spain Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Belgium Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure France Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Italy Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Denmark Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Finland Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Norway Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Sweden Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Poland Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Russia Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Turkey Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Table APAC Radiopharmaceuticals in Nuclear Medicine Consumption Forecast by Country (2022-2028)
- Figure China Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Japan Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure India Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure South Korea Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Pakistan Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Bangladesh Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Indonesia Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Thailand Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Singapore Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Malaysia Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Philippines Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Vietnam Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Table South America Radiopharmaceuticals in Nuclear Medicine Consumption Forecast by Country (2022-2028)
- Figure Brazil Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Colombia Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Chile Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Argentina Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Venezuela Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Peru Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Puerto Rico Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Ecuador Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Table GCC Radiopharmaceuticals in Nuclear Medicine Consumption Forecast by Country (2022-2028)
- Figure Bahrain Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Kuwait Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Oman Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Qatar Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure United Arab Emirates Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Table Africa Radiopharmaceuticals in Nuclear Medicine Consumption Forecast by Country (2022-2028)
- Figure Nigeria Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure South Africa Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Egypt Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Algeria Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Table Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Forecast by Country (2022-2028)
- Figure Australia Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure New Zealand Radiopharmaceuticals in Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)

Radiopharmaceuticals in Nuclear Medicine Market Report

Global Radiopharmaceuticals in Nuclear Medicine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

1. Global Radiopharmaceuticals in Nuclear Medicine Executive Summary

2 Coronavirus Impact

3 Strategic Analytics to Boost Productivity and Profitability

4 Key Inferences

5 Market Overview

6 Global Radiopharmaceuticals in Nuclear Medicine Market- Recent Developments

7 Radiopharmaceuticals in Nuclear Medicine Raw Materials and Cost Structure Analysis

8 Global Radiopharmaceuticals in Nuclear Medicine Import and Export Analysis (Top 10 Countries)

9 Global Radiopharmaceuticals in Nuclear Medicine Market Outlook by Types and Applications to 2022

10 Region and Country-wise Radiopharmaceuticals in Nuclear Medicine Market Analysis and Outlook till 2022

11 Global Radiopharmaceuticals in Nuclear Medicine Competitive Analysis

12 Global Radiopharmaceuticals in Nuclear Medicine Market Outlook by Types and Applications to 2028

13 Country-wise Radiopharmaceuticals in Nuclear Medicine Market Analysis and Outlook to 2028

14 Conclusions

The List of Tables and Figures

Report Version Choose

Our Customers

Beyond Consulting, Future is Feasible

Quick Link

CONTACT US